In this webinar we will share with the audience VIVEbiotech´s approach for developing lentiviral vectors from very early stages to GMP, considering highly relevant aspects such as scalability, regulatory compliance, and cost-effectiveness. Different manufacturing steps such as transient transfection using the PEIpro® reagent from Polyplus-transfection will be described.

Attendees will grow their understanding of :

  • LVV production requirements for scalability, regulatory compliance, and cost-effectiveness from early stages through to GMP.
  • How an optimized production process can be adapted to several intermediate scales, streamlining various developmental phases.
  • How to integrally manage LVV quality throughout the duration of the development project.
  • Quality being a key feature of suitability for the final product, we will also overview concepts of quality control and quality assurance.

Watch Webinar



Webinar published on Bioinsights website and made in partnership with VIVEbiotech.

Learn more



PEIpro® Product range


GMP compliant residual PEIpro® test: one step closer to commercialization

View All Resources